BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Greco A, Rizzo MI, De Virgilio A, Gallo A, Fusconi M, Pagliuca G, Martellucci S, Turchetta R, De Vincentiis M. Cancer stem cells in laryngeal cancer: what we know. Eur Arch Otorhinolaryngol 2016;273:3487-95. [DOI: 10.1007/s00405-015-3837-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Oloyo AK, Seriki AL, Udu CM, Adewole AR, Abdul Razak MM, Ismail-badmus KB. Evaluation of the Growth Suppressing and Stemness Inhibiting Effect of Cisplatin and 5 Fluorouracil on Human Epithelial Squamous Cell Carcinoma (HEp-2). EJMED 2022;4:53-59. [DOI: 10.24018/ejmed.2022.4.6.1104] [Reference Citation Analysis]
2 Mishra A, Pathak Y, Mishra SK, Prakash H, Tripathi V. Natural compounds as a potential modifier of stem cells renewal: Comparative analysis. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.175412] [Reference Citation Analysis]
3 Lv Y, Wang Y, Zhang Z. Potentials of lncRNA-miRNA-mRNA networks as biomarkers for laryngeal squamous cell carcinoma. Hum Cell 2022. [PMID: 36181662 DOI: 10.1007/s13577-022-00799-x] [Reference Citation Analysis]
4 Shen Y, Huang Q, Zhang Y, Hsueh CY, Zhou L. A novel signature derived from metabolism-related genes GPT and SMS to predict prognosis of laryngeal squamous cell carcinoma. Cancer Cell Int 2022;22:226. [PMID: 35804447 DOI: 10.1186/s12935-022-02647-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bisht S, Nigam M, Kunjwal SS, Sergey P, Mishra AP, Sharifi-rad J, Sorrenti V. Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting. Stem Cells International 2022;2022:1-28. [DOI: 10.1155/2022/9653244] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Song M, Liu X, Li T, Zhang Y, Zhao X, Sun W, Li Z. Silencing PLOD2 attenuates cancer stem cell-like characteristics and cisplatin-resistant through Integrin β1 in laryngeal cancer. Transl Oncol 2022;22:101460. [PMID: 35660870 DOI: 10.1016/j.tranon.2022.101460] [Reference Citation Analysis]
7 Ouban A. Expression of SALL4 stemness marker in laryngeal squamous cell carcinomas (LSCCs) and its clinical significance. All Life 2021;14:799-808. [DOI: 10.1080/26895293.2021.1972349] [Reference Citation Analysis]
8 Xiao H, Su QS, Li CQ. Identification of prognostic immune genes in laryngeal cancer. J Int Med Res 2020;48:300060520964662. [PMID: 33147419 DOI: 10.1177/0300060520964662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Li Z, Qu Y, Yang Y, An W, Li S, Wang B, He Y, Li J, Shao Q, Qin L. Prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index in patients with laryngeal squamous cell carcinoma. Clin Otolaryngol 2021;46:395-405. [PMID: 33321001 DOI: 10.1111/coa.13689] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Huang H, Hao J, Pang K, Lv Y, Wan D, Wu C, Ma Y, Yang X, Zhang WK. A biflavonoid-rich extract from Selaginella moellendorffii Hieron. induces apoptosis via STAT3 and Akt/NF-κB signalling pathways in laryngeal carcinoma. J Cell Mol Med 2020;24:11922-35. [PMID: 32869923 DOI: 10.1111/jcmm.15812] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
11 Rizzo MI, Ralli M, Nicolazzo C, Gradilone A, Carletti R, Di Gioia C, De Vincentiis M, Greco A. Detection of circulating tumor cells in patients with laryngeal cancer using ScreenCell: Comparative pre- and post-operative analysis and association with prognosis. Oncol Lett 2020;19:4183-8. [PMID: 32391112 DOI: 10.3892/ol.2020.11528] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
12 Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, Zhang G, Wang X, Dong Z, Chen F, Cui H. Targeting cancer stem cell pathways for cancer therapy. Sig Transduct Target Ther 2020;5. [DOI: 10.1038/s41392-020-0110-5] [Cited by in Crossref: 459] [Cited by in F6Publishing: 504] [Article Influence: 229.5] [Reference Citation Analysis]
13 Yuan Z, Xiu C, Liu D, Zhou G, Yang H, Pei R, Ding C, Cui X, Sun J, Song K. Long noncoding RNA LINC-PINT regulates laryngeal carcinoma cell stemness and chemoresistance through miR-425-5p/PTCH1/SHH axis. J Cell Physiol 2019;234:23111-22. [PMID: 31131448 DOI: 10.1002/jcp.28874] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
14 Luo S, Xie C, Wu P, He J, Tang Y, Xu J, Zhao S. Annexin A2 is an independent prognostic biomarker for evaluating the malignant progression of laryngeal cancer. Exp Ther Med. 2017;14:6113-6118. [PMID: 29285166 DOI: 10.3892/etm.2017.5298] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]